All posts

Shareholder activism could push Espial higher, says PI

A potential board shakeup could be a positive for Espial (Espial Stock Quote, Chart, News: TSX:ESP) shareholders, says PI analyst David Kwan.

Yesterday, Espial announced that it had received notice from shareholder Vantage Asset Management of four director nominees who may be put forward for election to the board of directors at the coming annual and special meeting of shareholders on June 13.

Kwan says he view this development as a positive that could unlock value.

“Low insider ownership creates opportunity for change,” says Kwan. “Although execution has improved in recent quarters, the shares have remained range-bound since Q4 FY2015 (following the plunge after the announcement of the potential loss of Rogers) which has likely frustrated certain shareholders and possibly helped lead to this vent. The low insider ownership (<5%) means Vantage has one less obstacle to implement the changes it desires.”

In a research update to clients today, Kwan maintained his “Buy” rating and one-year price target of $2.85 on Espial Group.

Kwan thinks Espial will post Adjusted EBITDA of negative $1.7-million on revenue of $38.3-million in fiscal 2017. He expects these numbers will improve to EBITDA of positive $8.3-million on a topline of $53.6-million the following year.

“Espial is attractively valued given a superior organic growth profile, pristine balance sheet, and discount valuation, with key near-term catalysts including Tier 1 customer wins and now shareholder activism potentially driving the stock out of its current (depressed) trading range,” Kwan says.

More Cantech Analysts

Tagged with: esp
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you sell your Cingulate stock?

In a Sept. 18 report, Roth Capital Markets analyst Boobalan Pachaiyappan reiterated a “Buy” rating and US$10.00 target on Cingulate… [Read More]

1 day ago

This Canadian smallcap stockhas big potential, analyst says

In a Sept. 17 report, Haywood Capital Markets analyst Gianluca Tucci said a new memorandum of understanding signed by MineHub… [Read More]

2 days ago

Quebecor wins price target raise at National Bank

National Bank Financial analyst Adam Shine raised his price target on Quebecor (Quebecor Stock Quote, Chart, News, Analysts, Financials TSE:QBR.B)… [Read More]

2 days ago

Cipher Pharmaceuticals is about to ramp up, Stifel says

In a Sept. 16 note, Stifel analyst Justin Keywood reiterated a “Buy” rating and C$20.00 target on Cipher Pharmaceuticals (Cipher… [Read More]

2 days ago

High Tide is building momentum, this analyst says

In a Sept. 15 note, Roth Capital Markets analyst Bill Kirk reiterated a “Buy” rating and $5.00 price target on… [Read More]

4 days ago

Rogers Communications named a “Best Idea” at TD Cowen

In its Canada Best Ideas 2025 report, TD Cowen analyst Vince Valentini reiterated his “Buy” rating on Rogers Communications (Rogers… [Read More]

4 days ago